UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi39-vi50

2013

Volltextzugriff (PDF)

Intraplacental choriocarcinoma: Systematic review and management guidance

Gynecologic oncology, 2016-06, Vol.141 (3), p.624-631

2016

Volltextzugriff (PDF)

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database

Gynecologic oncology, 2019-02, Vol.152 (2), p.361-367

2019

Volltextzugriff (PDF)

Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report

Gynecologic oncology reports, 2023-10, Vol.49, p.101259, Article 101259

2023

Volltextzugriff (PDF)

Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature

Gynecologic oncology reports, 2023-10, Vol.49, p.101281, Article 101281

2023

Volltextzugriff (PDF)

A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom

Gynecologic oncology, 2015-02, Vol.136 (2), p.258-263

2015

Volltextzugriff (PDF)

Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations

Placenta (Eastbourne), 2013-01, Vol.34 (1), p.50-56

2013

Volltextzugriff (PDF)

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2012-06, Vol.125 (3), p.576-579

2012

Volltextzugriff (PDF)

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy

BJOG : an international journal of obstetrics and gynaecology, 2003-01, Vol.110 (1), p.22-26

2003

Volltextzugriff (PDF)

A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites

International journal of gynecological cancer, 2008-01, Vol.18 (1), p.43-50

2008

Volltextzugriff (PDF)

Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate

Gynecologic oncology reports, 2021-05, Vol.36, p.100782, Article 100782

2021

Volltextzugriff (PDF)

18F FDG positron-emission tomography findings of gliomatosis peritonei: A case report and review of the literature

Gynecologic oncology reports, 2017-05, Vol.20 (C), p.105-107

2017

Volltextzugriff (PDF)

Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors

Journal of clinical oncology, 2000-02, Vol.18 (4), p.854-859

2000

Volltextzugriff (PDF)

1500TiP REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design

Annals of oncology, 2023-10, Vol.34, p.S845-S845

2023

Volltextzugriff (PDF)

Risk of recurrent molar pregnancies following complete and partial hydatidiform moles

Human reproduction (Oxford), 2015-09, Vol.30 (9), p.2055-2063

2015

Volltextzugriff (PDF)

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

European journal of cancer (1990), 2019-03, Vol.109, p.162-171

2019

Volltextzugriff (PDF)

An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis

Oncogene, 2011-08, Vol.30 (32), p.3513-3521

2011

Volltextzugriff (PDF)

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)

Annals of oncology, 2008-09, Vol.19 (9), p.1578-1583

2008

Volltextzugriff (PDF)

Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset

Annals of oncology, 2017-08, Vol.28 (8), p.1856-1861

2017

Volltextzugriff (PDF)

Diagnosis and Management of Gestational Trophoblastic Disease: 2021 Update

Obstetric anesthesia digest, 2023-03, Vol.43 (1), p.8-9

2023

Volltextzugriff (PDF)

373 Src family kinases in lung cancer

European journal of cancer supplements, 2010, Vol.8 (5), p.95-95

2010

Volltextzugriff (PDF)

Risk of recurrent molar pregnancies following complete and partial hydatidiform moles

Human reproduction (Oxford), 2016-06, Vol.31 (6), p.1379-1379

2016

Volltextzugriff (PDF)

361 Targeting phosphoinositide 3-kinase signalling in small cell lung cancer

European journal of cancer supplements, 2010, Vol.8 (5), p.92-92

2010

Volltextzugriff (PDF)

Control of gp130 expression by the mitogen-activated protein kinase ERK2

Oncogene, 2014-04, Vol.33 (17), p.2255-2263

2014

Volltextzugriff (PDF)

Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?

European journal of obstetrics & gynecology and reproductive biology, 2019-03, Vol.234, p.117-119

2019

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Intraplacental choriocarcinoma: Systematic review and management guidance

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database

Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report

Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature

A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom

Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy

A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites

Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate

18F FDG positron-emission tomography findings of gliomatosis peritonei: A case report and review of the literature

Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors

1500TiP REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design

Risk of recurrent molar pregnancies following complete and partial hydatidiform moles

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)

Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset

Diagnosis and Management of Gestational Trophoblastic Disease: 2021 Update

373 Src family kinases in lung cancer

Risk of recurrent molar pregnancies following complete and partial hydatidiform moles

361 Targeting phosphoinositide 3-kinase signalling in small cell lung cancer

Control of gp130 expression by the mitogen-activated protein kinase ERK2

Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?

Suchergebnisse filtern